| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 2 buys and 25 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2018 | Thorp Clay62 | Director, 10% Owner | Sell | 161,139 | $13.08 | $2,107,589.24 | -2.3% | |
| Mar 23, 2018 | Deignan Charles A.69 | Chief Financial Officer | Buy | 500 | $11.79 | $5,895.00 | +0.8% | |
| Mar 23, 2018 | Thorp Clay62 | Director, 10% Owner | Sell | 138,861 | $12.21 | $1,695,790.72 | -1.3% | |
| Mar 22, 2018 | Cagle Gerald D. | Director | Buy | 7,500 | $11.89 | $89,175.00 | +47.0% | |
| Dec 7, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 35,000 | $6.22 | $217,550.00 | -0.3% | |
| Nov 16, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 35,000 | $7.00 | $245,100.00 | -0.3% | |
| Oct 19, 2017 | White Daniel H. | President And CEO | Sell | 8,000 | $7.82 | $62,520.00 | -0.8% | |
| Oct 5, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 35,000 | $8.57 | $299,900.00 | -0.3% | |
| Sep 15, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 24,500 | $7.52 | $184,185.00 | -0.2% | |
| Sep 8, 2017 | White Daniel H. | President And CEO | Sell | 16,000 | $7.57 | $121,080.00 | -1.5% |